HARROW, INC. — Director's Dealing 2016

Feb 3, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2016-02-01

Reporting Person: BOLL ANDREW R. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-01	Common Stock	M	15000	$3.68	Acquired	202500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-01	Stock Option (Right to Buy)	$3.68	M	15000	Disposed	2016-02-01	Common Stock (15000)	Direct

Footnotes

F1: The stock option is fully exercisable.

F2: The stock option was granted on February 1, 2012 under the Issuer's 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3-year period, with 1/36th of the total number of shares subject to the stock option vesting each monthly period following its grant date.